🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/2016 | 53,63 | 53,93 | 53,39 | 53,75 | +0,12% | 1,01% | 7.012.168 |
| 31/05/2016 | 53,90 | 54,12 | 53,51 | 53,68 | -0,39% | 1,13% | 9.922.988 |
| 27/05/2016 | 53,91 | 54,24 | 53,65 | 53,89 | +0,16% | 1,08% | 7.869.222 |
| 26/05/2016 | 53,88 | 54,12 | 53,76 | 53,81 | -0,32% | 0,67% | 5.995.084 |
| 25/05/2016 | 53,25 | 54,07 | 53,22 | 53,98 | +1,74% | 1,61% | 10.052.626 |
| 24/05/2016 | 52,70 | 53,33 | 52,65 | 53,05 | +1,24% | 1,29% | 6.614.138 |
| 23/05/2016 | 52,48 | 52,70 | 52,27 | 52,40 | -0,34% | 0,82% | 5.837.674 |
| 20/05/2016 | 52,32 | 53,00 | 52,13 | 52,59 | +0,97% | 1,66% | 9.047.489 |
| 19/05/2016 | 51,68 | 52,46 | 51,60 | 52,08 | -0,16% | 1,66% | 9.153.127 |
| 18/05/2016 | 51,90 | 52,43 | 51,69 | 52,17 | +0,64% | 1,43% | 7.745.978 |
| 17/05/2016 | 51,92 | 52,07 | 51,51 | 51,83 | -0,60% | 1,08% | 12.360.112 |
| 16/05/2016 | 51,31 | 52,26 | 51,14 | 52,15 | +1,43% | 2,19% | 6.968.257 |
| 13/05/2016 | 51,62 | 52,01 | 51,36 | 51,41 | -0,44% | 1,26% | 7.467.210 |
| 12/05/2016 | 52,09 | 52,12 | 51,46 | 51,64 | -0,35% | 1,26% | 8.640.026 |
| 11/05/2016 | 52,19 | 52,28 | 51,77 | 51,82 | -0,68% | 0,97% | 6.888.399 |
| 10/05/2016 | 51,98 | 52,22 | 51,90 | 52,18 | +1,07% | 0,62% | 6.797.538 |
| 09/05/2016 | 51,12 | 51,84 | 51,06 | 51,62 | +0,93% | 1,53% | 8.358.219 |
| 06/05/2016 | 51,36 | 51,50 | 50,63 | 51,15 | -0,91% | 1,69% | 11.031.562 |
| 05/05/2016 | 51,79 | 51,91 | 50,90 | 51,61 | -1,31% | 1,95% | 11.764.010 |
| 04/05/2016 | 52,20 | 52,52 | 51,98 | 52,30 | -0,49% | 1,04% | 8.075.888 |
| 03/05/2016 | 52,61 | 52,91 | 52,34 | 52,56 | -0,40% | 1,09% | 7.966.058 |
| 02/05/2016 | 52,34 | 52,82 | 52,19 | 52,77 | +0,84% | 1,20% | 10.143.487 |
| 29/04/2016 | 53,09 | 53,09 | 52,06 | 52,33 | -1,61% | 1,94% | 13.862.944 |
| 28/04/2016 | 53,33 | 53,65 | 53,01 | 53,19 | -1,01% | 1,22% | 9.531.246 |
| 27/04/2016 | 53,49 | 54,03 | 53,49 | 53,73 | +0,48% | 1,00% | 7.274.587 |
| 26/04/2016 | 53,83 | 53,84 | 53,31 | 53,47 | -0,32% | 0,97% | 7.573.477 |
| 25/04/2016 | 53,89 | 54,05 | 53,44 | 53,65 | -0,92% | 1,13% | 8.677.650 |
| 22/04/2016 | 54,09 | 54,42 | 53,92 | 54,14 | +0,25% | 0,92% | 7.433.988 |
| 21/04/2016 | 53,76 | 54,42 | 53,73 | 54,01 | +0,04% | 1,28% | 11.040.994 |
| 20/04/2016 | 54,53 | 54,77 | 53,86 | 53,99 | -0,49% | 1,68% | 8.929.903 |